Literature DB >> 17360108

An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.

Guiqin Hou1, Lexun Xue, Zhaoming Lu, Tianli Fan, Fang Tian, Yanli Xue.   

Abstract

mTOR/p70S6K pathway is considered a central regulator in various malignant tumors, but its roles in esophageal squamous cell carcinoma (ESCC), which is a common cause of mortality in China, remain unknown. Here, we identify that the mTOR/p70S6K pathway is activated in ESCC; rapamycin and siRNA against mTOR rapidly inhibited expression of mTOR and the phosphorylation of its major downstream effectors, p70S6K and 4E-BP1, arrested cells in the G(0)/G(1) phase and induced apoptosis of ESCC cells. The findings may lay a foundation for making further investigations on the mTOR/p70S6K pathway as a potential target for ESCC therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360108     DOI: 10.1016/j.canlet.2007.01.026

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  56 in total

1.  Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients.

Authors:  Meng Chen; Jian Gu; George L Delclos; Ann M Killary; Zhen Fan; Michelle A T Hildebrandt; Robert M Chamberlain; H Barton Grossman; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2010-06-07       Impact factor: 4.944

2.  High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.

Authors:  Chi-Ju Yeh; Wen-Yu Chuang; Yin-Kai Chao; Yun-Hen Liu; Yu-Sun Chang; Shao-Yun Kuo; Chen-Kan Tseng; Hsien-Kun Chang; Chuen Hsueh
Journal:  Virchows Arch       Date:  2010-11-03       Impact factor: 4.064

3.  Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells.

Authors:  Lili Wang; Lexun Xue; Hongxia Yan; Jie Li; Yucheng Lu
Journal:  Mol Biol Rep       Date:  2009-08-02       Impact factor: 2.316

4.  Wnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia.

Authors:  Yan Chen Shang; Zhao Zhong Chong; Shaohui Wang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2012-11       Impact factor: 1.990

Review 5.  Translating cell survival and cell longevity into treatment strategies with SIRT1.

Authors:  K Maiese; Z Z Chong; Yan Chen Shang; S Wang
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

6.  mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis.

Authors:  Quan Zhou; Zhansheng Deng; Yong Zhu; Haitao Long; Shaoxian Zhang; Jiali Zhao
Journal:  Med Oncol       Date:  2009-11-20       Impact factor: 3.064

7.  Jaridonin, a novel ent-kaurene diterpenoid from Isodon rubescens, inducing apoptosis via production of reactive oxygen species in esophageal cancer cells.

Authors:  Yong-Cheng Ma; Yu Ke; Xiaolin Zi; Wen Zhao; Xiao-Jing Shi; Hong-Min Liu
Journal:  Curr Cancer Drug Targets       Date:  2013-07       Impact factor: 3.428

8.  The expression of URGCP gene in prostate cancer cell lines: correlation with rapamycin.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; Sunde Yılmaz Susluer; N Lale Satıroğlu Tufan; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2012-09-25       Impact factor: 2.316

9.  A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.

Authors:  Boris Shor; Druie Cavender; Crafford Harris
Journal:  BMC Immunol       Date:  2009-05-20       Impact factor: 3.615

10.  The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray.

Authors:  Li Xiao; Yi C Wang; Wu S Li; Yan Du
Journal:  J Exp Clin Cancer Res       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.